Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA-cp rat model of the metabolic syndrome

British Journal of Nutrition

Volumn 105, Issue 11, 2011, Pages 1572-1582

  Lu, Jing ^a   Borthwick, Faye ^a   Hassanali, Zahra ^a   Wang, Ye ^a   Mangat, Rabban ^a   Ruth, Megan ^a   Shi, Danni ^a   Jaeschke, Anja ^b   Russell, James C ^a   Field, Catherine J ^a   Proctor, Spencer D ^a   Vine, Donna F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

CVD; Dietary interventions; Dyslipidaemia; Metabolic syndrome

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; APOLIPOPROTEIN B48; CHOLESTEROL; FATTY ACID SYNTHASE; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; DYSLIPIDEMIA; GASTROINTESTINAL TRACT FUNCTION; GENE EXPRESSION; GENE TARGETING; INSULIN RESISTANCE; INTESTINE CELL; LIPID BLOOD LEVEL; LIPID METABOLISM; LIVER LEVEL; LONG TERM CARE; MALE; METABOLIC SYNDROME X; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTPRANDIAL STATE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; RISK REDUCTION; STAINING; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ANIMALS; BODY WEIGHT; CARDIOVASCULAR DISEASES; DIET; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; DYSLIPIDEMIAS; EATING; ENTEROCYTES; FATTY ACIDS, OMEGA-3; GENE EXPRESSION REGULATION; JEJUNUM; LIPIDS; LYMPH; MALE; METABOLIC SYNDROME X; MYOCARDIUM; OBESITY; POSTPRANDIAL PERIOD; RANDOM ALLOCATION; RATS;

RATTUS; RODENTIA;

EID: 79958769479     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510005453     Document Type: Article

References (56)

1. Alberti KG, Zimmet P & Shaw J (2006) Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23, 469-480.
2. Grundy SM, Brewer B, Cleeman JI, et al. (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433-438. (Pubitemid 38133916)
3. Alipour A, Elte JWF, van Zaanen HCT, et al. (2008) Novel aspects of postprandial lipemia in relation to atherosclerosis. Atheroscler Suppl 9, 39-44.
4. Despres JP & Marette A (1994) Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipidol 5, 274-289. (Pubitemid 24249562)
5. Russell JC, Amy RM, Graham SE, et al. (1995) Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by beta, beta0-tetramethylhexadecanedioic acid (MEDICA 16). Atheroscler Thromb Vasc Biol 15, 918-923.
6. Russell JC, Graham SE & Richardson M (1998) Cardiovascular disease in the JCR:LA-cp rat. Mol Cell Biochem 188, 113-126. (Pubitemid 28493324)
7. Brindley DN & Russell JC (2002) Animal models of insulin resistance and cardiovascular disease: some therapeutic approaches using JCR:LA-cp rat. Diabetes Obes Metab 4, 1-10. (Pubitemid 34285262)
8. Schwalfenberg G (2006) Omega-3 fatty acids: their beneficial role in cardiovascular health. Can Fam Physician 52, 734-740. (Pubitemid 44406056)
9. Carpentier YA, Portois L & Malaisse WJ (2006) n-3 Fatty acids and the metabolic syndrome. Am J Clin Nutr 6, 1499-1504.
10. Psota TL, Gebauer SK & Kris-Etherton P (2006) Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol 98, 3-18. (Pubitemid 44223360)
11. Von Schacky C & Harris WS (2007) Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res 73, 310-315. (Pubitemid 44937689)
12. Xiao YF, Sigg DC, Ujhelyi MR, et al. (2008) Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias. Am J Physiol Heart Circ Physiol 294, 2212-2218.
13. Mozaffarian D (2008) Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death. Am J Clin Nutr 87, 1991-1996.
14. Anandan R, Mathew S, Sankar TV, et al. (2007) Protective effect of n-3 polyunsaturated fatty acids concentrate on isoproterenol-induced myocardial infarction in rats. Prostag Leukotr Ess 76, 153-158. (Pubitemid 46366655)
15. Metcalf RG, James MJ, Gibson RA, et al. (2007) Effects of fishoil supplementation on myocardial fatty acids in humans. Am J Clin Nutr 85, 1222-1228. (Pubitemid 46740462)
16. Hassanali Z, Ametaj B, Field CJ, et al. (2010) Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat. Diabetes Obes Metab 12, 139-147.
17. Russell JC, Koeslag DG, Amy RM, et al. (1989) Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats. Arteriosclerosis 9, 869-876. (Pubitemid 20002219)
18. Russell JC, Graham S & Hameed M (1994) Abnorml insulin and glucose metabolism in the JCR:LA-corpulent rat. Metabolism 43, 538-543. (Pubitemid 24145457)
19. Elam MB, Wilcox HG, Cagen LM, et al. (2001) Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat. J Lipid Res 42, 2039-2048. (Pubitemid 34001053)
20. Mangat R, Su J, Scott PG, et al. (2007) Chylomicron and apoB48 metabolism in the JCR:LA-cp corpulent rat, a model for the metabolic syndrome. Biochem Soc Trans 35, 477-481. (Pubitemid 46975056)
21. Vance JE & Russell JC (1990) Hypersecretion of VLDL, but not HDL, by hepatocyes from the JCR:LA-corpulent rat. J Lipid Res 31, 1491-1501. (Pubitemid 20261913)
22. Vine DF, Takechi R, Russell JC, et al. (2007) Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome. Atherosclerosis 190, 282-290. (Pubitemid 46074043)
23. Wang Y, Jacome-Sosa M, Ruth MR, et al. (2009) Hypolipidemic trans-11 vaccenic acid reduces hepatic lipogenesis and chylomicron secretion in JCR:LA-cp rats. J Nutr 139, 2049-2054.
24. Weiser MM (1973) Intestinal epithelial cell surface membrane glycoprotein synthesis. J Biol Chem 248, 2536-2541.
25. Vine DF, Glimm DR & Proctor SD (2008) Intestinal lipid transport and chylomicron production: possible links to exacerbated atherogenesis in a rodent model of the metabolic syndrome. Atheroscler Suppl 9, 69-76.
26. Smith D, Proctor SD & Mamo JC (1997) A highly sensitive assay for quantitation of apolipoprotein B48 using an antibody to human apolipoprotein B and enhanced chemiluminescence. Ann Clin Biochem 34, 185-189. (Pubitemid 27121042)
27. Russell JC, Koeslag DG, Dolphin PJ, et al. (1990) Prevention of myocardial lesions in JCR:LA-corpulent rats by nifedipine. Arteriosclerosis 10, 658-664. (Pubitemid 20220591)
28. Thorsdottir I, Tomasson H, Gunnarsdottir I, et al. (2007) Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes 31, 1560-1566. (Pubitemid 47482660)
29. Mori TA, Bao DQ, Burke V, et al. (1999) Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 70, 817-825. (Pubitemid 29512906)
30. Summers LK, Fielding BA, Bradshaw HA, et al. (2002) Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 45, 369-377. (Pubitemid 34267359)
31. Bilby TR, Jenkins T, Staples CR, et al. (2006) Pregnancy, bovine somatotropin, and dietary n-3 fatty acids in lactating dairy cows: III. Fatty acid distribution. J Dairy Sci 89, 3386-3399. (Pubitemid 44305981)
32. Soriguer F, Moreno F, Rojo-Martínez G, et al. (2003) Redistribution of abdominal fat after a period of food restriction in rats is related to the type of dietary fat. Br J Nutr 89, 115-122. (Pubitemid 36187544)
33. Storlien LH, Kriketos AD, Jenkins AB, et al. (1997) Does dietary fat influence insulin action? Ann N Y Acad Sci 827, 287-301. (Pubitemid 27480273)
34. Neschen S, Moore I, Regittnig W, et al. (2002) Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content. Am J Physiol Endocrinol Metab 282, 395-401.
35. Feskens EJ, Loeber JG & Kromhout D (1994) Diet and physical activity as determinants of hyperinsulinemia: the Zutphen Elderly Study. Am J Epidemiol 140, 350-360. (Pubitemid 24257931)
36. Lombardo YB, Hein G & Chicco A (1997) Metabolic syndrome: effects of n-3 PUFAs on a model of dyslipidemia, insulin resistance and adiposity. Lipids 42, 427-437.
37. Russell JC, Amy RM & Dolphin PJ (1991) Effect of dietary n-3 fatty acids on atherosclerosis prone JCR:LA-corpulent rats. Exp Mol Pathol 55, 285-293.
38. Ukropec J, Reseland RE, Gasperikova D, et al. (2003) The hypotriglyceridemic effect of dietary n-3 FA is associated with increased beta-oxidation and reduced leptin expression. Lipids 38, 1023-1029. (Pubitemid 37444625)
39. Higuchi T, Shirai N, Saito M, et al. (2008) Levels of plasma insulin, leptin and adiponectin, and activites of key enzymes in carbohydrate metabolism in skeletal muscle and liver in fasted ICR mice fed dietary n-3 polyunsaturated fatty acids. J Nutr Biochem 19, 577-586.
40. Matsuzawa Y, Funahashi T & Shimomura I (2004) Adiponectin and metabolism syndrome. Arterioscler Thromb Vasc Biol 24, 29-33.
41. Lombardo YB & Chicco AG (2006) Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. J Nutr Biochem 17, 1-13. (Pubitemid 41774400)
42. Davidson MH (2006) Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 98, 27-33. (Pubitemid 44223362)
43. Weber LW, Boll M & Stampfl A (2004) Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins. World J Gastroenterol 10, 2081-2087.
44. Gallardo N, Bonzon-Kulichenko E, Fernandez-Agullo T, et al. (2007) Tissue-specific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue. Endocrinology 148, 5604-5610. (Pubitemid 350146140)
45. Yoshikawa T, Shimano H, Yahagi N, et al. (2002) Polyunsaturated fatty acids suppress sterol regulatory elementbinding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 277, 1705-1711. (Pubitemid 34968740)
46. Takeuchi Y, Yahagi N, Izumida Y, et al. (2010) Polyunsaturated fatty acids selectively suppress sterol regultory element-binding protein-1 through proteolytic processing and autoloop regultory circuit. J Biol Chem 285, 11681-11691.
47. Di Nunzio M, van Deursen D, Verhoeven AJM, et al. (2010) n-3 and n-6 Polyunsaturated fatty acids suppress sterol regulatory element binding protein activity and increase flow of non-esterified cholesterol in HepG2 cells. Br J Nutr 103, 161-167.
48. Kliewer SA, Sundseth SS, Jones SA, et al. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94, 4318-4323. (Pubitemid 27194239)
49. Kim HJ, Takahashi M & Ezaki O (1999) Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mRNAs. J Biol Chem 274, 25892-25898.
50. Mater MK, Thelen AP, Pan DA, et al. (1999) Sterol response element-binding protein 1c (SREBP1c) is involved in the polyunsaturated fatty acid suppression of hepatic S14 gene transcription. J Biol Chem 274, 32725-32732. (Pubitemid 129535302)
51. Price PT, Nelson CM & Clarke SD (2000) Omega-3 polyunsaturated fatty acid regulation of gene expression. Curr Opin Lipidol 11, 3-7. (Pubitemid 30148192)
52. Kersten S (2001) Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO 2, 282-286. (Pubitemid 32401521)
53. Oh da Y, Talukdar S, Bae EJ, et al. (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698.
54. Baldassarre D, Amato M, Eligini S, et al. (2006) Effect of n-3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: a doubleblind pilot study in primary prevention. Ann Med 38, 367-375.
55. Russell JC, Ewart HS, Kelly SE, et al. (2002) Improvement of vascular dysfunction and blood lipids of insulin-resistant rats by a marine oil-based phytosterol compound. Lipids 37, 147-152. (Pubitemid 34213980)
56. Wang Y, Lu J, Ruth MR, et al. (2008) Trans-11 vaccenic acid dietary supplementation induces hypolipidemic benefits in JCR:LA-cp rats. J Nutr 138, 2117-2122.